HomeInvestors HealthENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing...

ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements

525-5250815_gold-ball-free-png-gold-ball-png-clipart

August 28, 2024

ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements

Source link

Previous article

Where New Investors Should Be Looking to Buy This Fall

Next article

Nvidia Has Delivered Another Blowout Quarter and Looks Poised for More Big Wins

Investors Health Image

latest articles

explore more

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here